InvestorsHub Logo
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: ash111 post# 7028

Wednesday, 08/08/2018 8:44:07 AM

Wednesday, August 08, 2018 8:44:07 AM

Post# of 7536
YTEN Yield10 Bioscience Signs Research License Agreement Covering CRISPR-Cas9 Genome-Editing Technology with the Broad Institute and Pioneer. DD below. Monsanto is another solid reason.. Link back to DD

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.